Executive chairman of Loblaw Companies Limited Galen G. Weston and Chair of the Board of Directors of Shoppers Drug Mart Holger Kluge (R) speak during a news conference in Toronto, July 15, 2013.MARK BLINCH/Reuters
Loblaw Cos. Ltd. struck a $12.4-billion deal for Shoppers Drug Mart Corp. Monday. Here is The Globe's complete coverage of the major acquisition:
NEWS
Loblaw's bulk buy: $12.4-billion deal for Shoppers creates a colossus of retail
Galen G. Weston's plan to grow his family's legacy
Loblaw and Shoppers by the numbers
Loblaw, Empire deals pushing up neighbours' prices
What shoppers, analysts think about Loblaw deal
COMMENTARY & ANALYSIS
Loblaw's big bet on thinking small
Why would Shoppers agree not to shop for a better offer?
Loblaw looks to a new generation of shoppers
Not much for the Loblaw REIT in Shoppers deal
What does the Loblaw-Shoppers Drug Mart marriage mean for consumers?
How the Loblaw-Shoppers deal will affect your ETFs
Takeover lesson: Shoppers is no BlackBerry
For the bankers in the grocery wars, solo lending is key
Banks' willingness for risk made Loblaw deal possible
Shoppers purchase a strong play for Loblaw
VIDEO & MULTIMEDIA
Shoppers customers ask: What happens to my Optimum points?
Can Loblaw make the Shoppers deal work?
Loblaw's Weston says Shoppers deal happened quickly
Is Loblaw's Shoppers deal the right prescription for drug and food retail?